LathMized NAD+ Monthly Maintenance
LathMized NAD+
Stabilized NAD+ Compound
LathMized NAD+ Monthly Maintenance delivers a 30-day supply of stabilized NAD+ lozenges using intraMITOcell's proprietary LathMized technology. Designed as a follow-up to the intensive Load Up protocol or as a standalone daily regimen, these lozenges provide consistent NAD+ support for cellular energy production, immune function, and longevity. Unlike over-the-counter NAD+ supplements that may degrade in as few as 5 days at room temperature, LNAD+ lozenges remain stable and bioactive throughout the entire supply. Clinical studies backing the LathMized formulation demonstrated a 53% increase in intracellular NAD+ and a 25% increase in spinal cord NAD+ — results that support improvements in sleep, neurological health, mobility, cognition, and overall quality of life, even in healthy individuals.
Indications
Daily NAD+ maintenance, cellular energy support, longevity, sleep improvement, cognitive support, mood balance, anti-aging
- — Sustained daily NAD+ support with LathMized stabilization
- — Maintains elevated NAD+ levels after Load Up protocol
- — Supports cellular energy production and mitochondrial function
- — Improves sleep quality and circadian rhythm
- — Enhances cognitive clarity and mood balance
- — Convenient sublingual lozenge — no injections or IV required
- — Stable at room temperature unlike conventional NAD+ supplements
Price
$250
Medication Details
30-day supply
Concentration: 100 mg/day
Dosing
Daily (ongoing)
Administration
Oral (Lozenge)
Storage & Handling
Refrigerate after reconstitution (36°F–46°F / 2°C–8°C). Do not freeze. Protect from light. Discard after 90 days.
Notes
3,000 mg total, 30-day supply (100 mg/day). Dissolve lozenge sublingually as directed. Store at room temperature. Ideal as ongoing maintenance following the 7-day Load Up protocol. Consult provider for individualized regimen.
Consult your prescribing Healthcare Provider for dosing adjustments.
Disclaimer
This medication is compounded and provided for use only under the supervision of a licensed healthcare provider. Use only as prescribed. Individual results may vary.
Version 2.2 | Effective Date: January 31, 2026
